Adenosine A2A receptor is a unique angiogenic target of HIF-2α in pulmonary endothelial cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 26, 2009, Pages 10684-10689

  Ahmad, Aftab ^a   Ahmad, Shama ^a   Glover, Louise ^b   Miller, Stacy M ^a   Shannon, John M ^c   Guo, Xiaoling ^a   Franklin, Wilbur A ^b   Bridges, James P ^c   Schaack, Jerome B ^b   Colgan, Sean P ^b   White, Carl W ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Hypoxia inducible factors; Lung cancer

Indexed keywords

ADENOSINE A2A RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LUCIFERASE; SMALL INTERFERING RNA; ADENOSINE A2 RECEPTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CD31 ANTIGEN; DICARBOXYLIC AMINO ACID; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; MESSENGER RNA; OXALYLGLYCINE; VASCULOTROPIN A;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CONTROL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; LUNG CANCER; LUNG ENDOTHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION SITE; VIRUS MUTANT; ANIMAL; CELL CULTURE; CELL HYPOXIA; CELL LINE; CELL MOTION; CYTOLOGY; DNA RESPONSIVE ELEMENT; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION; GENETICS; LUNG; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

AMINO ACIDS, DICARBOXYLIC; ANIMALS; ANTIGENS, CD31; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; LUCIFERASES; LUNG; LUNG NEOPLASMS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS, GENETIC; RECEPTORS, ADENOSINE A2; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67649804934     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0901326106     Document Type: Article

References (67)

1. Semenza GL (2006) Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp Physiol 91:803-806. (Pubitemid 44266576)
2. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC (2003) Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23:9361-9374. (Pubitemid 37499822)
3. Kondo K, Kim WY, Lechpammer M, Kaelin WG, Jr (2003) Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. PLoS Biol 1:E83.
4. Patel SA, Simon MC (2008) Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ 15:628-634.
5. Giatromanolaki A, Sivridis E, Fiska A, Koukourakis MI (2006) Hypoxia-inducible factor-2 alpha (HIF-2 alpha) induces angiogenesis in breast carcinomas. Appl Immunohistochem Mol Morphol 14:78-82.
6. Holmquist-Mengelbier L, et al. (2006) Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10:413-423. (Pubitemid 44693470)
7. Koga F, et al. (2004) Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer. J Urol 171:1080-1084. (Pubitemid 38327531)
8. Lofstedt T, et al. (2007) Hypoxia inducible factor-2alpha in cancer. Cell Cycle 6:919-926.
9. Yoshimura H, et al. (2004) Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: Correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res 10:8554-8560. (Pubitemid 40053424)
10. Covello KL, et al. (2006) HIF-2alpha regulates Oct-4: Effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 20:557-570. (Pubitemid 43345322)
11. Aprelikova O, Wood M, Tackett S, Chandramouli GV, Barrett JC (2006) Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res 66:5641-5647. (Pubitemid 43927116)
12. Warnecke C, et al. (2004) Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: Erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J 18:1462-1464. (Pubitemid 39561615)
13. Chavez JC, Baranova O, Lin J, Pichiule P (2006) The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26:9471-9481. (Pubitemid 44396860)
14. Rankin EB, et al. (2007) Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117:1068-1077. (Pubitemid 46556763)
15. Oktay Y, et al. (2007) Hypoxia-inducible factor 2alpha regulates expression of the mitochondrial aconitase chaperone protein frataxin. J Biol Chem 282:11750-11756. (Pubitemid 47100692)
16. Scortegagna M, et al. (2003) Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet 35:331-340. (Pubitemid 37486916)
17. Daval JL, Nicolas F, Doriat JF (1996) Adenosine physiology and pharmacology: How about A2 receptors? Pharmacol Ther 71:325-335. (Pubitemid 26366376)
18. Nees S, Gerbes AL, Willershausen-Zonnchen B, Gerlach E (1979) Purine metabolism in cultured coronary endothelial cells. Adv Exp Med Biol 122B:25-30.
19. Ethier MF, Chander V, Dobson JG, Jr (1993) Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol 265:H131-H138.
20. Meininger CJ, Granger HJ (1990) Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells. Am J Physiol 258:H198-H206. (Pubitemid 20063129)
21. Feoktistov I, et al. (2002) Differential expression of adenosine receptors in human endothelial cells: Role of A2B receptors in angiogenic factor regulation. Circ Res 90:531-538. (Pubitemid 34640902)
22. Lasley RD, Jahania MS, Mentzer RM, Jr (2001) Beneficial effects of adenosine A(2a) agonist CGS-21680 in infarcted and stunned porcine myocardium. Am J Physiol Heart Circ Physiol 280:H1660-H1666.
23. Okusa MD, et al. (2000) A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol 279:F809-F818. (Pubitemid 30952023)
24. Peirce SM, Skalak TC, Rieger JM, Macdonald TL, Linden J (2001) Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation. Am J Physiol Heart Circ Physiol 281:H67-H74. (Pubitemid 32911777)
25. Cassada DC, et al. (2001) An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion. J Vasc Surg 34:482-488. (Pubitemid 33661182)
26. McPherson JA, et al. (2001) Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol 21:791-796. (Pubitemid 32448770)
27. Ross SD, et al. (1999) Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation. J Heart Lung Transplant 18:994-1002. (Pubitemid 29505488)
28. Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916-920. (Pubitemid 34024743)
29. Olanrewaju HA, Qin W, Feoktistov I, Scemama JL, Mustafa SJ (2000) Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 279:H650-H656. (Pubitemid 30672777)
30. Desai A, et al. (2005) Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol Pharmacol 67:1406-1413. (Pubitemid 40594139)
31. Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S (2000) Escape of human solid tumors from T-cell recognition: Molecular mechanisms and functional significance. Adv Immunol 74:181-273.
32. Lukashev D, Sitkovsky M, Ohta A (2007) From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy. Purinergic Signal 3:129-134.
33. Lukashev D, Ohta A, Sitkovsky M (2007) Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues. Cancer Metastasis Rev 26:273-279.
34. Sitkovsky MV (2009) T regulatory cells: Hypoxia-adenosinergic suppression and redirection of the immune response. Trends Immunol 30:102-108.
35. Asikainen TM, et al. (2005) Stimulation of HIF-1alpha, HIF-2alpha, and VEGF by prolyl 4-hydroxylase inhibition in human lung endothelial and epithelial cells. Free Radic Biol Med 38:1002-1013. (Pubitemid 40386546)
36. Yu L, et al. (2004) Characterization of genomic organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses. Brain Res 1000:156-173. (Pubitemid 38446500)
37. Kim TH, et al. (2005) Direct isolation and identification of promoters in the human genome. Genome Res 15:830-839.
38. Trinklein ND, Aldred SJ, Saldanha AJ, Myers RM (2003) Identification and functional analysis of human transcriptional promoters. Genome Res 13:308-312. (Pubitemid 36575778)
39. Montesinos MC, Shaw JP, Yee H, Shamamian P, Cronstein BN (2004) Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am J Pathol 164:1887-1892. (Pubitemid 38669338)
40. Feoktistov I, et al. (2004) Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension 44:649-654. (Pubitemid 39435234)
41. Tanaka T, et al. (2005) Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab Invest 85:1292-1307. (Pubitemid 41348643)
42. Tian H, McKnight SL, Russell DW (1997) Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11:72-82. (Pubitemid 27043825)
43. Hislop AA (2002) Airway and blood vessel interaction during lung development. J Anat 201:325-334. (Pubitemid 35244052)
44. Thebaud B, Abman SH (2007) Bronchopulmonary dysplasia: Where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 175:978-985. (Pubitemid 46741748)
45. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31.
46. Hu CJ, Sataur A, Wang L, Chen H, Simon MC (2007) The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell 18:4528-4542. (Pubitemid 350060179)
47. Lau KW, Tian YM, Raval RR, Ratcliffe PJ, Pugh CW (2007) Target gene selectivity of hypoxia-inducible factor-alpha in renal cancer cells is conveyed by post-DNA-binding mechanisms. Br J Cancer 96:1284-1292. (Pubitemid 46625064)
48. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP (2006) HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 20:2242-2250. (Pubitemid 44953854)
49. King J, et al. (2004) Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes. Microvasc Res 67:139-151. (Pubitemid 38327000)
50. Rankin EB, et al. (2008) Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 27:5354-5358.
51. Yamashita T, et al. (2008) Hypoxia-inducible transcription factor-2alpha in endothelial cells regulates tumor neovascularization through activation of ephrin A1. J Biol Chem 283:18926-18936.
52. Martin PL (1999) Adenosine agonists for the prevention of restenosis? IDrugs 2:44-51. (Pubitemid 29064294)
53. Sun CN, et al. (2006) Rescue of p53 blockage by the A(2A) adenosine receptor via a novel interacting protein, translin-associated protein X. Mol Pharmacol 70:454-466. (Pubitemid 44092306)
54. Trincavelli ML, et al. (2003) A(2A) adenosine receptor ligands and proinflammatory cytokines induce PC 12 cell death through apoptosis. Biochem Pharmacol 66:1953-1962. (Pubitemid 37352858)
55. Huang NK (2003) Adenosine A2A receptors regulate oxidative stress formation in rat pheochromocytoma PC12 cells during serum deprivation. Neurosci Lett 350:127-131. (Pubitemid 37101428)
56. Palmer TM, Stiles GL (1997) Identification of an A2a adenosine receptor domain specifically responsible for mediating short-term desensitization. Biochemistry 36:832-838. (Pubitemid 27110963)
57. Ohta A, et al. (2006) A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA 103:13132-13137. (Pubitemid 44338928)
58. Bangoura G, et al. (2007) Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma. World J Gastroenterol 13:3176-3182. (Pubitemid 47064579)
59. Raval RR, et al. (2005) Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 25:5675-5686. (Pubitemid 40853601)
60. Nasarre P, et al. (2009) Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth. Cancer Res 69:1324-1333.
61. Chikazawa M, Inoue K, Fukata S, Karashima T, Shuin T (2008) Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder. Pathobiology 75:335-345.
62. Sitkovsky MV, Kjaergaard J, Lukashev D, Ohta A (2008) Hypoxia-adenosinergic immunosuppression: Tumor protection by T regulatory cells and cancerous tissue hypoxia. Clin Cancer Res 14:5947-5952.
63. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML (2002) Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295:858-861. (Pubitemid 34118367)
64. Masson N, Willam C, Maxwell PH, Pugh CW, Ratcliffe PJ (2001) Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J 20:5197-5206. (Pubitemid 32910914)
65. He TC, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509-2514. (Pubitemid 28145972)
66. Ahmad A, Ahmad S, Chang LY, Schaack J, White CW (2006) Endothelial Akt activation by hyperoxia: Role in cell survival. Free Radic Biol Med 40:1108-1118.
67. Schaack J, Langer S, Guo X (1995) Efficient selection of recombinant adenoviruses by vectors that express beta-galactosidase. J Virol 69:3920-3923.